Amwill Healthcare IPO is a book-built issue worth Rs 59.98 crores, consisting of a fresh issue of 44.04 lakh shares aggregating to Rs 48.88 crores and an offer for sale of 10.00 lakh shares amounting to Rs 11.10 crores.
The subscription for the Amwill Healthcare IPO opened on February 5, 2025, and will close on February 7, 2025. The allotment process is expected to be finalized on Monday, February 10, 2025. The IPO is set to list on the BSE SME, with a tentative listing date scheduled for Wednesday, February 12, 2025.
Amwill Healthcare operates in the derma-cosmetic sector. They specialize in developing dermatological and aesthetic solutions, collaborating with contract manufacturers, distributors, and third-party product development agencies. Their products target various skin-related concerns, such as acne, fungal infections, anti-ageing, and more.
The price band for the Amwill Healthcare IPO is fixed between ₹105 and ₹111 per share. Investors can apply for a minimum lot size of 1,200 shares. Retail investors must make a minimum investment of ₹1,33,200, while high-net-worth individuals (HNI) need to apply for at least 2 lots (2,400 shares), amounting to ₹2,66,400.
Unistone Capital Pvt Ltd is the book-running lead manager for the Amwill Healthcare IPO, with Bigshare Services Pvt Ltd serving as the registrar for the issue. The market-making responsibilities will be handled by Globalworth Securities Limited.
Amwill Healthcare IPO Details:
| Company Name | Amwill Healthcare Limited |
| Sector | Derma-Cosmetic |
| IPO Type | SME |
| IPO Open date | 05th Feb 2025 |
| IPO Close date | 07th Feb 2025 |
| Listing Exchanges | BSE |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
Amwill Healthcare IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 1200 | 1,33,200 |
| HNI (Min) | 2 | 2400 | 2,64,400 |
Amwill Healthcare IPO Timeline:
| IPO Open Date | 05th Feb 2025 |
| IPO Close Date | 07th Feb 2025 |
| Basis of Allotment | 10th Feb 2025 |
| Refund Initiation Date | 11th Feb 2025 |
| Shares Credit to Demat | 11th Feb 2025 |
| Listing Date | 12th Feb 2025 |
Things to Consider before applying for an IPO
Financial Performance: Review Amwill Healthcare’s Financials to understand its revenue, profitability, and growth prospects.
Industry Outlook: Consider the overall health of India’s Derma-Cosmetic Industry.
Valuation: Compare the price band to similar companies in the industry to see if the IPO is priced fairly.
Management Team: Research the experience and capabilities of the management team.
Our Verdict
This IPO offers a good opportunity to invest in Amwill Healthcare and be a part of its growth.
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
